PHASE IV, MULTICENTER, OPEN LABEL, RANDOMIZED, PILOT CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND THE CONVENIENCE OF SWITCHING ART TO B/F/TAF IN WELLSUPPRESSED HIV-INFECTED PATIENTS HARBORING CNS VULNERABILITIES

• ACRONYM: MIND
• FSG CODE: GESIDA 11920
• COORDINATOR: IGNACIO PÉREZ VALERO
• COORDINATOR’S HOSPITAL: HOSPITAL UNIVERSITARIO REINA SOFIA, CÓRDOBA, ANDALUCÍA
• APPROVAL DATE: 9-SEP.-2020
• PROTOCOL STATUS: ANALYZING DATA / PUBLISHED 
• CEIC-S APPROVAL: YES
• AEMYPS APPROVAL: YES
• ENROLED PATIENTS: 80
• TOTAL NUMBER OF PATIENTS TO INCLUDE: 80
• SCIENTIFIC OUTPUT: RELEASE